Shenzhen Kangtai Biological Products Co Ltd (300601) - Total Liabilities

Latest as of March 2026: CN¥4.32 Billion CNY ≈ $632.34 Million USD

Based on the latest financial reports, Shenzhen Kangtai Biological Products Co Ltd (300601) has total liabilities worth CN¥4.32 Billion CNY (≈ $632.34 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shenzhen Kangtai Biological Products Co Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Shenzhen Kangtai Biological Products Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Shenzhen Kangtai Biological Products Co short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Shenzhen Kangtai Biological Products Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shenzhen Kangtai Biological Products Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
American Superconductor Corporation
NASDAQ:AMSC
USA $184.03 Million
Mesoblast Ltd
AU:MSB
Australia AU$207.62 Million
Dgb Financial
KO:139130
Korea ₩96.18 Trillion
FAIRFAX INDIA HLDGS
F:F5X
Germany €772.00 Million
Vietnam National Petroleum Group
VN:PLX
Vietnam ₫77.19 Trillion
Surgery Partners Inc
NASDAQ:SGRY
USA $4.39 Billion
Horace Mann Educators Corporation
NYSE:HMN
USA $13.50 Billion
EMBOTELL. ANDINA ADR A/6
F:AKOA
Germany €2.13 Trillion

Liability Composition Analysis (2012–2025)

This chart breaks down Shenzhen Kangtai Biological Products Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Shenzhen Kangtai Biological Products Co .

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.87 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.45 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.31 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen Kangtai Biological Products Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen Kangtai Biological Products Co Ltd (2012–2025)

The table below shows the annual total liabilities of Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥4.46 Billion
≈ $653.20 Million
-8.95%
2024-12-31 CN¥4.90 Billion
≈ $717.42 Million
-11.56%
2023-12-31 CN¥5.54 Billion
≈ $811.21 Million
+15.47%
2022-12-31 CN¥4.80 Billion
≈ $702.54 Million
-3.64%
2021-12-31 CN¥4.98 Billion
≈ $729.06 Million
+134.89%
2020-12-31 CN¥2.12 Billion
≈ $310.38 Million
+77.03%
2019-12-31 CN¥1.20 Billion
≈ $175.33 Million
-20.32%
2018-12-31 CN¥1.50 Billion
≈ $220.03 Million
+31.93%
2017-12-31 CN¥1.14 Billion
≈ $166.77 Million
+31.62%
2016-12-31 CN¥865.90 Million
≈ $126.71 Million
+26.09%
2015-12-31 CN¥686.71 Million
≈ $100.49 Million
-9.44%
2014-12-31 CN¥758.25 Million
≈ $110.96 Million
+3.20%
2013-12-31 CN¥734.74 Million
≈ $107.52 Million
+4.14%
2012-12-31 CN¥705.50 Million
≈ $103.24 Million
--

About Shenzhen Kangtai Biological Products Co Ltd

SHE:300601 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.88 Billion
CN¥12.87 Billion CNY
Market Cap Rank
#6506 Global
#1402 in China
Share Price
CN¥11.52
Change (1 day)
-0.17%
52-Week Range
CN¥11.49 - CN¥20.49
All Time High
CN¥148.10
About

Shenzhen Kangtai Biological Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of human vaccines in China and internationally. The company offers 13-valent pneumococcal polysaccharide conjugate vaccines (TT/DT); varicella vaccines (freeze-dried); hepatitis B vaccines; 23-valent pneumococcal polysaccharide vaccines; diphtheria tetanus ace… Read more